JP2019511918A5 - - Google Patents

Download PDF

Info

Publication number
JP2019511918A5
JP2019511918A5 JP2018545182A JP2018545182A JP2019511918A5 JP 2019511918 A5 JP2019511918 A5 JP 2019511918A5 JP 2018545182 A JP2018545182 A JP 2018545182A JP 2018545182 A JP2018545182 A JP 2018545182A JP 2019511918 A5 JP2019511918 A5 JP 2019511918A5
Authority
JP
Japan
Prior art keywords
gene
rodent
tmprss
humanized
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018545182A
Other languages
English (en)
Japanese (ja)
Other versions
JP6980674B2 (ja
JP2019511918A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/019574 external-priority patent/WO2017151453A1/en
Publication of JP2019511918A publication Critical patent/JP2019511918A/ja
Publication of JP2019511918A5 publication Critical patent/JP2019511918A5/ja
Application granted granted Critical
Publication of JP6980674B2 publication Critical patent/JP6980674B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018545182A 2016-02-29 2017-02-27 ヒト化tmprss遺伝子を有する齧歯類 Active JP6980674B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662301023P 2016-02-29 2016-02-29
US62/301,023 2016-02-29
PCT/US2017/019574 WO2017151453A1 (en) 2016-02-29 2017-02-27 Rodents having a humanized tmprss gene

Publications (3)

Publication Number Publication Date
JP2019511918A JP2019511918A (ja) 2019-05-09
JP2019511918A5 true JP2019511918A5 (enExample) 2020-04-09
JP6980674B2 JP6980674B2 (ja) 2021-12-15

Family

ID=58264641

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018545182A Active JP6980674B2 (ja) 2016-02-29 2017-02-27 ヒト化tmprss遺伝子を有する齧歯類

Country Status (14)

Country Link
US (5) US10070632B2 (enExample)
EP (2) EP3895529A1 (enExample)
JP (1) JP6980674B2 (enExample)
KR (2) KR102775366B1 (enExample)
CN (1) CN109068621B (enExample)
AU (1) AU2017228293B2 (enExample)
CA (1) CA3014645C (enExample)
DK (1) DK3422845T3 (enExample)
ES (1) ES2886958T3 (enExample)
IL (1) IL261139B (enExample)
PT (1) PT3422845T (enExample)
RU (1) RU2749715C2 (enExample)
SG (2) SG11201807038UA (enExample)
WO (1) WO2017151453A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2749715C2 (ru) 2016-02-29 2021-06-16 Регенерон Фармасьютикалз, Инк. Грызуны, характеризующиеся гуманизированным геном tmprss
KR102544051B1 (ko) * 2017-09-29 2023-06-16 리제너론 파마슈티칼스 인코포레이티드 인간화된 ttr 유전자좌를 포함하는 비인간 동물 및 사용 방법
CA3089377A1 (en) 2018-01-26 2019-08-01 Regeneron Pharmaceuticals, Inc. Anti-tmprss2 antibodies and antigen-binding fragments
SMT202400300T1 (it) 2018-07-16 2024-09-16 Regeneron Pharma Modelli di roditori della sindrome ditra e loro utilizzo
AU2020209184A1 (en) 2019-01-17 2021-07-08 Regeneron Pharmaceuticals, Inc. A rodent model of mood disorders
KR20220140503A (ko) 2020-02-10 2022-10-18 리제너론 파마슈티칼스 인코포레이티드 항-tmprss2 항체 및 항원 결합 단편
CN115161326B (zh) * 2021-06-21 2024-09-24 百奥赛图(北京)医药科技股份有限公司 Sost基因人源化非人动物及其构建方法和应用
US20250049006A1 (en) 2021-12-20 2025-02-13 C/O Regeneron Pharmaceuticals, Inc. Non-human animals comprising humanized ace2 and tmprss loci

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002065266A (ja) * 2000-08-28 2002-03-05 Teijin Ltd 気道特異的トリプシン様酵素およびその利用法
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
WO2003053136A2 (en) * 2001-12-20 2003-07-03 The Regents Of The University Of California Triple transgenic mouse model of alzheimer's disease
US20050026255A1 (en) * 2002-06-25 2005-02-03 Morser John Michael Corin, a serine protease
JP2006507813A (ja) * 2002-10-04 2006-03-09 シエーリング アクチエンゲゼルシャフト 置換体活性化配列を有する修飾されたヘプシン分子及びその使用
MXPA05013321A (es) * 2003-06-11 2006-03-09 Schering Ag Nuevas moleculas modificadas de corina que tienen secuencias de activacion sustitutiva y sus usos.
US7491865B2 (en) * 2004-08-19 2009-02-17 Fred Hutchinson Cancer Research Center Mouse models of prostate cancer development and metastasis through expression of a hepsin transgene
AU2005295269B2 (en) 2004-10-19 2010-05-13 Regeneron Pharmaceuticals, Inc. Method for generating an animal homozygous for a genetic modification
PL2019837T3 (pl) * 2006-05-23 2011-09-30 Irm Llc Związki i kompozycje jako inhibitory proteazy aktywującej kanały
GB0821624D0 (en) * 2008-11-26 2008-12-31 Eisai London Res Lab Ltd Assay
AU2010203353B2 (en) * 2009-01-12 2016-06-16 Cytomx Therapeutics, Inc Modified antibody compositions, methods of making and using thereof
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
JP5874881B2 (ja) 2009-10-06 2016-03-02 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 遺伝子改変されたマウスおよび移植方法
EP2675271B1 (en) * 2011-02-15 2018-06-13 Regeneron Pharmaceuticals, Inc. Humanized m-csf mice
PL2663575T3 (pl) 2011-10-28 2015-03-31 Regeneron Pharma Humanizowane IL-6 i receptor IL-6
HRP20220616T1 (hr) 2011-10-28 2022-06-24 Regeneron Pharmaceuticals, Inc. Genetski modificirani miš koji eksprimira kimerne molekule glavnog kompleksa histokompatibilnosti (mhc) ii
PT2770821T (pt) 2011-10-28 2017-12-18 Regeneron Pharma Ratinhos de complexo principal de histocompatibilidade principal modificados geneticamente
US9498529B2 (en) * 2012-04-16 2016-11-22 Regeneron Pharmaceuticals, Inc. Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
AU2013278075B2 (en) * 2012-06-22 2018-05-17 Cytomx Therapeutics, Inc. Anti-jagged 1/Jagged 2 cross-reactive antibodies, activatable anti-Jagged antibodies and methods of use thereof
KR102340059B1 (ko) 2012-09-07 2021-12-17 예일 유니버시티 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법
US9901082B2 (en) 2012-11-05 2018-02-27 Regeneron Pharmaceuticals, Inc. Genetically modified non-human animals and methods of use thereof
SG10201706741VA (en) 2013-02-20 2017-10-30 Regeneron Pharma Genetic modification of rats
KR102369454B1 (ko) 2013-02-20 2022-03-04 리제너론 파아마슈티컬스, 인크. 사람화된 t-세포 보조-수용체를 발현하는 마우스
CN110192541B (zh) 2013-02-22 2022-02-18 瑞泽恩制药公司 表达人源化主要组织相容性复合物的小鼠
US20150342163A1 (en) 2013-02-22 2015-12-03 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex mice
BR112015026197B1 (pt) 2013-04-16 2022-12-06 Regeneron Pharmaceuticals, Inc Método para modificação marcada de um lócus genômico de interesse em uma célula de rato pluripotente
CN116063479A (zh) 2013-06-04 2023-05-05 西托姆克斯治疗公司 用于缀合可活化抗体的组合物和方法
SG11201601184UA (en) 2013-09-23 2016-03-30 Regeneron Pharma Non-human animals having a humanized signal-regulatory protein gene
US9155290B2 (en) 2013-10-15 2015-10-13 Regeneron Pharmaceuticals, Inc. Humanized IL-15 animals
WO2015077071A1 (en) 2013-11-19 2015-05-28 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized b-cell activating factor gene
CN105792647B (zh) 2013-11-19 2018-10-02 瑞泽恩制药公司 具有人源化的增殖诱导配体基因的非人动物
CN106163273B (zh) 2014-04-08 2020-07-24 瑞泽恩制药公司 具有人源化FC-γ受体的非人动物
NO2785538T3 (enExample) 2014-05-07 2018-08-04
KR102821645B1 (ko) 2014-05-19 2025-06-19 리제너론 파마슈티칼스 인코포레이티드 인간 epo를 발현하는 유전자 변형된 비-인간 동물
US10390522B2 (en) 2014-06-19 2019-08-27 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized programmed cell death 1 gene
MX2017006802A (es) 2014-11-24 2018-01-30 Regeneron Pharma Animales no humanos que expresan el complejo cd3 humanizado.
TR201903891T4 (tr) 2014-12-05 2019-04-22 Regeneron Pharma Bir insanlaştırılmış farklılaşma kümesi 47 genine sahip olan insan dışı hayvanlar.
HRP20202034T1 (hr) 2014-12-09 2021-02-19 Regeneron Pharmaceuticals, Inc. Neljudske životinje s genom za humanizirani diferencijacijski biljeg cd274
DK3280257T3 (da) 2015-04-06 2023-09-04 Regeneron Pharma Humaniseret T-celle-formidlet immunrespons i ikke-humane dyr
JP6997708B2 (ja) 2015-11-20 2022-02-04 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒト化されたlymphocyte-activation gene 3遺伝子を有する非ヒト動物
RU2749715C2 (ru) * 2016-02-29 2021-06-16 Регенерон Фармасьютикалз, Инк. Грызуны, характеризующиеся гуманизированным геном tmprss
KR101693243B1 (ko) 2016-06-15 2017-01-05 재단법인 한국파스퇴르연구소 인플루엔자 바이러스의 복제에 관여하는 신규 인간 유전자 및 이의 용도

Similar Documents

Publication Publication Date Title
JP2019511918A5 (enExample)
JP7477675B2 (ja) 組織選択的導入遺伝子発現
JP2017514501A5 (enExample)
JP2019047818A5 (enExample)
JP2017213006A5 (enExample)
KR102213535B1 (ko) pH-민감성 면역글로불린 서열을 발현하는 비-사람 동물
HRP20231121T1 (hr) Životinje koje nisu ljudi, koje imaju gen za humanizirani protein koji regulira signale
JP2018500896A5 (enExample)
RU2017123754A (ru) Не относящиеся к человеку животные, имеющие гуманизированный ген кластера дифференцировки 274
JP6884860B2 (ja) 操作されたイムノグロブリンラムダ軽鎖座位を有する非ヒト動物
JP2017521060A5 (enExample)
HRP20200613T1 (hr) Neljudske životinje koje imaju humanizirani gen 1 za programiranu staničnu smrt
RU2018131152A (ru) Грызуны, характеризующиеся гуманизированным геном tmprss
JP2015523863A5 (enExample)
JP2019022518A5 (enExample)
HRP20231707T1 (hr) Životinje koje nisu ljudi, koje sadrže humanizirani gen iz diferencijacijske skupine 47
JP6636486B2 (ja) ヒト化ジペプチジルペプチダーゼiv(dpp4)動物
RU2016143036A (ru) Не относящиеся к человеку животные, имеющие гуманизированные fc-гамма-рецепторы
JP2020515292A5 (enExample)
RU2016143376A (ru) ЖИВОТНЫЕ С ГУМАНИЗИРОВАННЫМИ IL-4 И IL-4Rα
FI3823443T3 (fi) Ditra-taudin jyrsijämallit ja niiden käyttö
KR102487839B1 (ko) 조작된 angptl8 유전자를 갖는 비인간 동물
JP2016172780A5 (enExample)
Baust et al. Insertional polymorphisms of ETn retrotransposons include a disruption of the wiz gene in C57BL/6 mice.
Jiang et al. Hearing restoration by gene replacement therapy for a multisite-expressed gene in a mouse model of human DFNB111 deafness